Dopamine agonists for preventing ovarian hyperstimulation syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dopamine Agonists for Preventing Ovarian Hyperstimulation Syndrome." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436192/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome. Accessed 10 October 2024.
Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436192/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome. Accessed October 10, 2024.
Dopamine agonists for preventing ovarian hyperstimulation syndrome. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436192/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome
Dopamine Agonists for Preventing Ovarian Hyperstimulation Syndrome [Internet]. In: Cochrane Abstracts. [cited 2024 October 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436192/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dopamine agonists for preventing ovarian hyperstimulation syndrome
ID - 436192
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436192/all/Dopamine_agonists_for_preventing_ovarian_hyperstimulation_syndrome
DB - Evidence Central
DP - Unbound Medicine
ER -